Review Article| Volume 32, ISSUE 4, P517-525, October 2014

Download started.


Botulinum Toxin for Hyperhidrosis of Areas Other than the Axillae and Palms/Soles


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lear W.
        • Kessler E.
        • Solish N.
        • et al.
        An epidemiological study of hyperhidrosis.
        Dermatol Surg. 2007; 33: S69-S75
        • Glaser D.A.
        • Hebert A.A.
        • Pariser D.M.
        • et al.
        Facial hyperhidrosis: best practice recommendations and special considerations.
        Cutis. 2007; 79: 29-32
        • Rystedt A.
        • Swartling C.
        • Naver H.
        Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.
        Acta Derm Venereol. 2008; 88: 229-233
        • El Kahky H.M.
        • Diab H.M.
        • Aly D.G.
        • et al.
        Efficacy of onabotulinum toxin A (Botox) versus abobotulinum toxin A (Dysport) using a conversion factor (1: 2.5) in treatment of primary palmar hyperhidrosis.
        Dermatol Res Pract. 2013; 2013: 1-6
        • Vergilis-Kalner I.J.
        Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
        J Drugs Dermatol. 2011; 10: 1013-1015
        • Rosell K.
        • Hymnelius K.
        • Swartling C.
        Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
        Acta Derm Venereol. 2013; 93: 335-339
        • Campanati A.
        • Giuliodori K.
        • Giuliano A.
        • et al.
        Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach.
        Arch Dermatol Res. 2013; 305: 691-697
        • Hsu T.S.
        • Dover J.S.
        • Arndt K.A.
        Effect of volume and concentration on the diffusion of botulinum exotoxin A.
        Arch Dermatol. 2004; 140: 1351-1354
        • Trindade De Almeida A.R.
        • Marques E.
        • De Almeida J.
        • et al.
        Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis.
        Dermatol Surg. 2007; 33: S37-S43
        • Anders D.
        • Moosbauer S.
        • Naumann M.K.
        • et al.
        Craniofacial hyperhidrosis successfully treated with botulinum toxin type A.
        Eur J Dermatol. 2008; 18: 87-88
        • George S.M.
        • Atkinson L.R.
        • Farrant P.B.
        • et al.
        Botulinum toxin for focal hyperhidrosis of the face.
        Br J Dermatol. 2014; 170 (Available at:) (Accessed November 19, 2013): 211-213
        • Geddoa E.
        • Balakumar A.K.
        • Paes T.R.
        The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
        Int J Dermatol. 2008; 47: 1079-1080
        • Komericki P.
        • Ardjomand N.
        Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A.
        Indian J Dermatol Venereol Leprol. 2012; 78: 201
        • Dorizas A.
        • Krueger N.
        • Sadick N.S.
        Aesthetic uses of the botulinum toxin.
        Dermatol Clin. 2014; 32: 23-36
        • Moeller K.
        • Esser D.
        • Boeger D.
        • et al.
        Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome.
        Eur Arch Oto Rhino Laryngol. 2012; 270: 1149-1155
        • Steffen A.
        • Rotter N.
        • König I.R.
        • et al.
        Botulinum toxin for Frey’s syndrome: a closer look at different treatment responses.
        J Laryngol Otol. 2011; 126: 185-189
        • Díaz P.M.
        • del Castillo R.B.
        • de la Plata M.M.
        • et al.
        Clinical results in the management of Frey’s Syndrome with injections of botulinum toxin.
        Med Oral Patol Oral Cir Bucal. 2008; 13: E248-E252
        • Guntinas-Lichius O.
        Increased botulinum toxin type A dosage is more effective in patients with Frey’s syndrome.
        Laryngoscope. 2002; 112: 746-749
        • Bechara F.G.
        • Sand M.
        • Achenbach R.K.
        • et al.
        Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
        Dermatol Surg. 2007; 33: 924-927
        • Hexsel D.M.
        • Dal’forno T.
        • Hexsel C.L.
        Inguinal, or Hexsel’s hyperhidrosis.
        Clin Dermatol. 2004; 22: 53-59
        • Woolery-Lloyd H.
        • Elsaie M.L.
        • Avashia N.
        Inguinal hyperhidrosis misdiagnosed as urinary incontinence: treatment with botulinum toxin A.
        J Drugs Dermatol. 2008; 7: 293-295
        • Barankin B.
        • Wasel N.
        Treatment of inguinal hyperhidrosis with botulinum toxin type A.
        Int J Dermatol. 2006; 45: 985-986
        • Kern U.
        • Kohl M.
        • Seifert U.
        • et al.
        Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study.
        Am J P M R. 2011; 90: 321-329
        • Sugimura H.
        • Spratt E.H.
        • Compeau C.G.
        • et al.
        Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility.
        J Thorac Cardiovasc Surg. 2009; 137: 1370-1378
        • Charrow A.
        • DiFazio M.
        • Foster L.
        • et al.
        Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series.
        Arch Phys Med Rehabil. 2008; 89: 1407-1409
        • Gratrix M.
        • Hivnor C.
        Botulinum toxin A treatment for hyperhidrosis in patients with prosthetic limbs.
        Arch Dermatol. 2010; 146: 1314
        • García-Morales I.
        • Pérez-Bernal A.
        • Camacho F.
        Letter: stump hyperhidrosis in a leg amputee: treatment with botulinum toxin A.
        Dermatol Surg. 2007; 33: 1401-1402
        • Currie A.C.
        • Evans J.R.
        • Thomas P.R.
        An analysis of the natural course of compensatory sweating following thoracoscopic sympathectomy.
        Int J Surg. 2011; 9: 437-439
        • Deng B.
        • Tan Q.Y.
        • Jiang Y.G.
        • et al.
        Optimization of sympathectomy to treat palmar hyperhidrosis: the systematic review and meta-analysis of studies published during the past decade.
        Surg Endosc. 2010; 25: 1893-1901
        • Kim W.O.
        • Kil H.K.
        • Yoon K.B.
        • et al.
        Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk.
        Dermatol Surg. 2009; 35: 833-838
        • Findikcioglu A.
        • Kilic D.
        • Hatipoglu A.
        Is clipping superior to cauterization in the treatment of palmar hyperhidrosis?.
        Thorac Cardiovasc Surg. 2013; ([Epub ahead of print])
        • Santana-Rodríguez N.
        • Clavo B.
        • Calatayud-Gastardi J.
        • et al.
        Severe compensatory hyperhidrosis following thoracic sympathectomy successfully treated with low doses of botulinum toxin A.
        J Dermatolog Treat. 2012; 23: 457-460